课题基金 / 基金详情

HNO-donating Prodrugs for Use as Pharmaceuticals and Biomedical Research Tools

HNO-donating Prodrugs for Use as Pharmaceuticals and Biomedical Research Tools
用作药物和生物医学研究工具的 HNO 供给前药
批准号:
7678195
负责人:
Debra J Salmon
金额:
$3.44万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2011-09-29

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Cyanamide is used clinically outside the United States as an alcohol deterrent drug. Bioactivation of cyanamide produces the metabolite nitroxyl (HNO), which acts as an inhibitor of aldehyde dehydrogenase (AIDH) via thiol modification. The resulting increase in blood acetaldehyde levels are accompanied by unpleasant symptoms that discourage continued use of alcohol. That cyanamide also produces cyanide upon bioactiviaton has restricted clinical approval in the United States. However, the efficacy and lower toxicity compared to existing approved alcohol deterrent agents suggests that HNO donors may serve to improve pharmacotherapy of alcohol abuse. Primary amine diazeniumdiolates (NONOates) having the general structure [RNHN(O)NO]- can be designed to be either NO or HNO donors. Furthermore, these compounds are amenable to prodrug-formation via O2- derivatization with protecting groups. This application focuses on development of HNO-donating NONOates that can be used as AIDH inhibitors but with the potential for fewer side effects compared to cyanamide or disulfiram. The specific aims of this application are 1) to synthesize and characterize a series of HNO releasing NONOates and prodrugs and 2) to analyze the pharmacological proficiency for AIDH inhibition and potential toxicity of HNO-donating NONOates. Completion of these aims will establish whether HNO donating NONOates can function as viable alternatives to cyanamide in the treatment of alcoholism and alcohol abuse. Nitroxyl (HNO) is a reactive, physiologically-relevant compound that has potential to positively impact diseases as diverse as heart failure and alcoholism. HNO is the active metabolite of cyanamide, which is used outside the United States for the treatment of chronic alcohol dependence. Due to the toxic byproducts of cyanamide, new HNO-donating compounds are desired to serve as alternative pharmacological agents for the treatment of alcohol abuse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金